Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach
Objective: To evaluate a new treatment for dysmenorrhea by mechanically inducing menstrual fluid streaming. Setting: A 4-month randomized double-blind, placebo-controlled, crossover study. Participants: Study participants included women experiencing dysmenorrhea monthly (for the 6 preceding months)...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Cogent Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2331205X.2018.1501933 |
id |
doaj-59e2a69717344709b401d4a2cafd619c |
---|---|
record_format |
Article |
spelling |
doaj-59e2a69717344709b401d4a2cafd619c2021-03-18T14:42:11ZengTaylor & Francis GroupCogent Medicine2331-205X2018-01-015110.1080/2331205X.2018.15019331501933Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approachHilla Shaviv0Doron J. D. Rosen1Yossef Ezra2GalMedics Biotech LtdMeir Medical CenterHadassah Hebrew University Medical CenterObjective: To evaluate a new treatment for dysmenorrhea by mechanically inducing menstrual fluid streaming. Setting: A 4-month randomized double-blind, placebo-controlled, crossover study. Participants: Study participants included women experiencing dysmenorrhea monthly (for the 6 preceding months) at a level >5 on the visual analog scale (0–10), who were otherwise healthy. The study participants also collected their menstrual fluid for 2 baseline months, while recording their pain levels (primary outcome) systematically. A correlation between menstrual fluid characteristics and menstrual pain was studied as well. Intervention: A newly invented device was used to attenuate dysmenorrheic pain level. Results: From September 2011 to December 2013, 28 study participants were enrolled; three withdrew and three were excluded for protocol non-adherence. Twenty-two study participants (132 menstrual cycles) who used the device reported an average reduction of 55 ± 7.6% in pain levels vs. 22 ± 12% reported with placebo (p = 0.008). In addition, analysis of menstrual fluid collected from 19 study participants (38 menstrual cycles) showed that high pain levels necessarily involve tissue fragments or a viscous menstrual fluid, supporting the idea that dysmenorrhea is associated with the rheological characteristics of the menstrual fluid. Conclusions: The new device is highly effective in relieving menstrual pain. Rheological characteristics of the menses are correlated with severity of dysmenorrhea.http://dx.doi.org/10.1080/2331205X.2018.1501933dysmenorrheamensesrandomized trialrheologyvaginal deviceactilady |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hilla Shaviv Doron J. D. Rosen Yossef Ezra |
spellingShingle |
Hilla Shaviv Doron J. D. Rosen Yossef Ezra Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach Cogent Medicine dysmenorrhea menses randomized trial rheology vaginal device actilady |
author_facet |
Hilla Shaviv Doron J. D. Rosen Yossef Ezra |
author_sort |
Hilla Shaviv |
title |
Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach |
title_short |
Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach |
title_full |
Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach |
title_fullStr |
Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach |
title_full_unstemmed |
Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach |
title_sort |
dysmenorrhea: a randomized controlled clinical trial evaluating a novel treatment approach |
publisher |
Taylor & Francis Group |
series |
Cogent Medicine |
issn |
2331-205X |
publishDate |
2018-01-01 |
description |
Objective: To evaluate a new treatment for dysmenorrhea by mechanically inducing menstrual fluid streaming. Setting: A 4-month randomized double-blind, placebo-controlled, crossover study. Participants: Study participants included women experiencing dysmenorrhea monthly (for the 6 preceding months) at a level >5 on the visual analog scale (0–10), who were otherwise healthy. The study participants also collected their menstrual fluid for 2 baseline months, while recording their pain levels (primary outcome) systematically. A correlation between menstrual fluid characteristics and menstrual pain was studied as well. Intervention: A newly invented device was used to attenuate dysmenorrheic pain level. Results: From September 2011 to December 2013, 28 study participants were enrolled; three withdrew and three were excluded for protocol non-adherence. Twenty-two study participants (132 menstrual cycles) who used the device reported an average reduction of 55 ± 7.6% in pain levels vs. 22 ± 12% reported with placebo (p = 0.008). In addition, analysis of menstrual fluid collected from 19 study participants (38 menstrual cycles) showed that high pain levels necessarily involve tissue fragments or a viscous menstrual fluid, supporting the idea that dysmenorrhea is associated with the rheological characteristics of the menstrual fluid. Conclusions: The new device is highly effective in relieving menstrual pain. Rheological characteristics of the menses are correlated with severity of dysmenorrhea. |
topic |
dysmenorrhea menses randomized trial rheology vaginal device actilady |
url |
http://dx.doi.org/10.1080/2331205X.2018.1501933 |
work_keys_str_mv |
AT hillashaviv dysmenorrheaarandomizedcontrolledclinicaltrialevaluatinganoveltreatmentapproach AT doronjdrosen dysmenorrheaarandomizedcontrolledclinicaltrialevaluatinganoveltreatmentapproach AT yossefezra dysmenorrheaarandomizedcontrolledclinicaltrialevaluatinganoveltreatmentapproach |
_version_ |
1724215774545969152 |